Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Xinyuan Liu, Xinyu Wang, Tao Mao, Xiaoyan Yin, Zhi Wei, Jindong Fu, Jie Wu & Xiaoyu Li. (2023) Characteristic analysis of early gastric cancer after Helicobacter pylori eradication: a multicenter retrospective propensity score-matched study. Annals of Medicine 55:1.
Read now
Read now
Yang-Kun Wang, Jun-Ling Zhou, Nian-Long Meng, Chao-Ya Zhu, Su-Nan Wang & Xiao-Dong Chen. (2022) How Does Helicobacter pylori Infection Cause Gastric Mucosal Atrophy. Infection and Drug Resistance 15, pages 3619-3629.
Read now
Read now
Katsuhiro Hanada & David Y Graham. (2014) Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinoma. Expert Review of Anticancer Therapy 14:8, pages 947-954.
Read now
Read now
Articles from other publishers (32)
Helge Waldum & Patricia Mjønes. (2023) The central role of gastrin in gastric cancer. Frontiers in Oncology 13.
Crossref
Crossref
Zhe-Xuan Li, Kathrin Bronny, Luca Formichella, Raquel Mejías-Luque, Teresa Burrell, Lukas Macke, Ulrich Lang, Riccardo Vasapolli, Olsi Hysenaj, Ingrid Stallforth, Michael Vieth, Wei-Cheng You, Yang Zhang, Sebastian Suerbaum, Christian Schulz, Kai-Feng Pan & Markus Gerhard. (2023) A multiserological line assay to potentially discriminate current from past Helicobacter pylori infection. Clinical Microbiology and Infection.
Crossref
Crossref
Takeshi Yasuda, Osamu Dohi, Shinya Yamada, Tsugitaka Ishida, Naoto Iwai, Hitoshi Hongo, Kei Terasaki, Makoto Tanaka, Nobuhisa Yamada, Kazuhiro Kamada, Ryusuke Horie, Akihito Harusato, Yusuke Horii, Shun Takayama, Keika Zen, Atsushi Majima, Naoki Mizuno, Takayuki Motoyoshi, Nobuaki Yagi, Yuji Naito & Yoshito Itoh. (2023) Risk and prognostic factors of invasive gastric cancer detection during surveillance endoscopy: Multi‐institutional cross‐sectional study. Digestive Endoscopy 35:5, pages 592-602.
Crossref
Crossref
. (2023) Aktualisierte S2k-Leitlinie Helicobacter
pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Juli 2022 – AWMF-Registernummer: 021–001. Zeitschrift für Gastroenterologie 61:05, pages 544-606.
Crossref
Crossref
Hee Seok Moon. (2023) Approach to Patients after Successful Eradication of Helicobacter pylori. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 23:1, pages 22-27.
Crossref
Crossref
Ping Wang, Peng Li, Yingxuan Chen, Li Li, Yuanyuan Lu, Weixun Zhou, Liqun Bian, Beihua Zhang, Xiaolan Yin, Junxiang Li, Jie Chen, Shutian Zhang, Yongquan Shi & Xudong Tang. (2022) Chinese integrated guideline on the management of gastric precancerous conditions and lesions. Chinese Medicine 17:1.
Crossref
Crossref
Yali Wei, Chen Jiang, Yiping Han, Wen Song, Xiaoyu Li & Xiaoyan Yin. (2022) Characteristics and background mucosa status of early gastric cancer after Helicobacter pylori eradication: A narrative review. Medicine 101:48, pages e31968.
Crossref
Crossref
Daichi Hara, Takuma Okamura, Yugo Iwaya, Tadanobu Nagaya, Hiroyoshi Ota & Takeji Umemura. (2022)
Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to
Helicobacter pylori
eradication is a risk factor for gastric cancer development
. Helicobacter 27:6.
Crossref
Crossref
Hajar El Filaly, Ahmed Outlioua, Hind Medyouf, Fadila Guessous & Khadija Akarid. (2022)
Targeting IL-1β in patients with advanced
Helicobacter pylori
infection: a potential therapy for gastric cancer
. Future Microbiology 17:8, pages 633-641.
Crossref
Crossref
Alba Panarese. (2022) Usefulness of artificial intelligence in early gastric cancer. WArtificial Intelligence in Cancer 3:2, pages 17-26.
Crossref
Crossref
Kensuke Fukuda, Masaaki Kodama, Kazuhiro Mizukami, Kazuhisa Okamoto, Ryo Ogawa, Yuka Hirashita, Masahide Fukuda, Kazumi Togo, Osamu Matsunari, Tadayoshi Okimoto & Kazunari Murakami. (2022) Analysis of long-term serological and histological changes after eradication of <i>Helicobacter pylori</i>. Journal of Clinical Biochemistry and Nutrition 71:2, pages 151-157.
Crossref
Crossref
Satoki Shichijo, Noriya Uedo & Tomoki Michida. (2022) Detection of Early Gastric Cancer after <b><i>Helicobacter pylori</i></b> Eradication. Digestion 103:1, pages 54-61.
Crossref
Crossref
V. T. Ivashkin, I. V. Maev, T. L. Lapina, E. D. Fedorov, A. A. Sheptulin, A. S. Trukhmanov, A. V. Kononov, R. A. Abdulkhakov, O. P. Alexeeva, S. A. Alekseenko, D. N. Andreev, E. K. BaranskayaN. N. Dekhnich, I. L. Klyaritskaya, R. S. Kozlov, E. A. KoganM. P. Korolev, N. V. Korochanskaya, S. A. Kurilovich, M. A. Livsan, M. F. Osipenko, P. V. PavlovS. S. Pirogov, A. S. Sarsenbaeva, V. I. Simanenkov, A. S. Tertychny, A. V. Tkachev, Yu. P. Uspensky, I. B. Khlynov & V. V. Tsukanov. (2021) Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 31:4, pages 70-99.
Crossref
Crossref
Inês Pita, Diogo Libânio & Pedro Pimentel Nunes. (2021) Diagnosis and Management of Epithelial Precancerous Conditions and Lesions in the Stomach. Current Treatment Options in Gastroenterology 19:2, pages 277-294.
Crossref
Crossref
Ombretta Repetto, Valli De Re, Paolo Giuffrida, Marco Vincenzo Lenti, Raffaella Magris, Marino Venerito, Agostino Steffan, Antonio Di Sabatino & Renato Cannizzaro. (2021) Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer. Gastric Cancer 24:3, pages 666-679.
Crossref
Crossref
Yuka Obayashi, Seiji Kawano, Hiroyuki Sakae, Makoto Abe, Yoshiyasu Kono, Hiromitsu Kanzaki, Masaya Iwamuro, Yoshiro Kawahara, Takehiro Tanaka, Hiroyuki Yanai & Hiroyuki Okada. (2021) Risk Factors for Gastric Cancer after the Eradication of <i>Helicobacter pylori</i> Evaluated Based on the Background Gastric Mucosa: A Propensity Score-matched Case-control Study. Internal Medicine 60:7, pages 969-976.
Crossref
Crossref
Shiyu Xiao, Yihan Fan, Zhihao Yin & Liya Zhou. (2020) Endoscopic grading of gastric atrophy on risk assessment of gastric neoplasia: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 36:1, pages 55-63.
Crossref
Crossref
Duc Trong Quach & Toru Hiyama. (2019) Assessment of Endoscopic Gastric Atrophy according to the Kimura-Takemoto Classification and Its Potential Application in Daily Practice. Clinical Endoscopy 52:4, pages 321-327.
Crossref
Crossref
Masaaki Kodama, Tadayoshi Okimoto, Kazuhiro Mizukami, Kensuke Fukuda, Ryo Ogawa, Kazuhisa Okamoto, Osamu Matsunari, Yoshinari Kawahara, Yuka Hirashita & Kazunari Murakami. (2019) Differences in <i>Helicobacter pylori</i> and CagA antibody changes after eradication between subjects developing and not developing gastric cancer. Journal of Clinical Biochemistry and Nutrition 65:1, pages 71-75.
Crossref
Crossref
Yuki Michigami, Jiro Watari, Chiyomi Ito, Keisuke Nakai, Takahisa Yamasaki, Takashi Kondo, Tomoaki Kono, Katsuyuki Tozawa, Toshihiko Tomita, Tadayuki Oshima, Hirokazu Fukui, Takeshi Morimoto, Kiron M. Das & Hiroto Miwa. (2018) Long-term effects of H. pylori eradication on epigenetic alterations related to gastric carcinogenesis. Scientific Reports 8:1.
Crossref
Crossref
Xing Zhang, Meng Li, Shuntai Chen, Jiaqi Hu, Qiujun Guo, Rui Liu, Honggang Zheng, Zhichao Jin, Yuan Yuan, Yupeng Xi & Baojin Hua. (2018) Endoscopic Screening in Asian Countries Is Associated With Reduced Gastric Cancer Mortality: A Meta-analysis and Systematic Review. Gastroenterology 155:2, pages 347-354.e9.
Crossref
Crossref
Hu Yue, Liu Shan & Lv Bin. (2018) The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis. Gastric Cancer 21:4, pages 579-587.
Crossref
Crossref
Satoki Shichijo & Yoshihiro Hirata. (2018) Characteristics and predictors of gastric cancer after Helicobacter pylori eradication. World Journal of Gastroenterology 24:20, pages 2163-2172.
Crossref
Crossref
Xian-Zhe Chen, Cheng-Zhi Huang, Wei-Xian Hu, Ying Liu & Xue-Qing Yao. (2018) Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations. Chinese Medical Journal 131:10, pages 1232-1239.
Crossref
Crossref
Masaaki Kodama, Tadayoshi Okimoto, Kazuhiro Mizukami, Hisanori Abe, Ryo Ogawa, Kazuhisa Okamoto, Mitsutaka Shuto, Osamu Matsunari, Yuka Hirashita, Ryugo Sato, Takashi Abe, Takayuki Nagai, Tsuyoshi Arita & Kazunari Murakami. (2018) Endoscopic and Immunohistochemical Characteristics of Gastric Cancer with versus without Helicobacter Pylori Eradication. Digestion 97:4, pages 288-297.
Crossref
Crossref
Bor-Shyang Sheu, Ming-Shiang Wu, Cheng-Tang Chiu, Jing-Chuan Lo, Deng-Chyang Wu, Jyh-Ming Liou, Chun-Ying Wu, Hsiu-Chi Cheng, Yi-Chia Lee, Ping-I Hsu, Chun-Chao Chang, Wei-Lun Chang & Jaw-Town Lin. (2017)
Consensus on the clinical management, screening-to-treat, and surveillance of
Helicobacter pylori
infection to improve gastric cancer control on a nationwide scale
. Helicobacter 22:3, pages e12368.
Crossref
Crossref
Osamu Toyoshima, Yutaka Yamaji, Shuntaro Yoshida, Shuhei Matsumoto, Hiroharu Yamashita, Takamitsu Kanazawa & Keisuke Hata. (2016) Endoscopic gastric atrophy is strongly associated with gastric cancer development after Helicobacter pylori eradication. Surgical Endoscopy 31:5, pages 2140-2148.
Crossref
Crossref
Toshihiro Nishizawa, Hidekazu Suzuki, Toru Arano, Shuntaro Yoshida, Hiroharu Yamashita, Keisuke Hata, Takanori Kanai, Naohisa Yahagi & Osamu Toyoshima. (2016) Characteristics of gastric cancer detected within 1 year after successful eradication of <i>Helicobacter pylori</i>. Journal of Clinical Biochemistry and Nutrition 59:3, pages 226-230.
Crossref
Crossref
Hai-Ning Chen, Zhu Wang, Xiao Li & Zong-Guang Zhou. (2015) Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Gastric Cancer 19:1, pages 166-175.
Crossref
Crossref
Miao Li, Jun Li, Zhaozhen Qi, Qiu Tang, Xiangyang Wang & Hongda Lu. (2015) Role of inflammatory gene variants in Helicobacter pylori-related gastric cancer ⁎. Oncology and Translational Medicine 1:3, pages 104-108.
Crossref
Crossref
Jan Bornschein, Andrea Dingwerth, Michael Selgrad, Marino Venerito, Patrick Stuebs, Katrin Frauenschlaeger, Achilleas Achilleos, Albert Roessner & Peter Malfertheiner. (2015) Adenocarcinomas at different positions at the gastro-oesophageal junction show distinct association with gastritis and gastric preneoplastic conditions. European Journal of Gastroenterology & Hepatology 27:5, pages 492-500.
Crossref
Crossref
Marco Pizzi, Deborah Saraggi, Matteo Fassan, Francis Megraud, Francesco Di Mario & Massimo Rugge. (2014) Secondary Prevention of Epidemic Gastric Cancer in the Model of <b><i>Helicobacter pylori</i></b>-Associated Gastritis. Digestive Diseases 32:3, pages 265-274.
Crossref
Crossref